Oncology Information Systems is well known for managing portfolios by software across healthcare settings, such as hospitals, research laboratories, and clinics. In addition, this software is useful to envisage treatment outcomes; accordingly, this software helps to plan the patient’s treatment, and also provide information about cancer patient among overall healthcare organizations. Furthermore, these advantages improve the efficiency and safety of cancer therapy for patients. Oncology information systems help surgeons and physicians to choose the most suitable therapy to develop the survival rate for cancer patients.
The key factors that drive the market growth include ease of use of different cancer therapies, such as radiation therapy, and chemotherapy, and the existence of a huge cancer population. During the envisaged period, the market is likely to witness moderate growth, due to the benefits offered by oncology information systems over conventional methods of record keeping and treatment planning. The factors that are anticipated to boost the market growth include the surge in the prevalence of cancer and rising in technological advancements, such as incorporation of patients portals. Furthermore, there are various opportunities for expanding markets such as the use of oncology information systems to treat rare cancer and advance improvements in the technology by the use of artificial intelligence. However, the factors likely to hinder the market growth include lack of healthcare IT professionals and high costs associated with oncology information systems.
Oncology Information Systems market is segmented into an application such as Medical Oncology, Surgical Oncology, Radiation Oncology. In 2017, medical oncology dominated the global oncology information systems market and is likely to grow during the upcoming year. The oncology information system manages software, analyzes, interprets, and stores the patient information competently. Furthermore, this software also assists to expect the treatment outcome for patients; it develops to improve the survival rate of the patient and drives the growth of the oncology information systems market.
The market research study on “Oncology Information Systems Market (Products & Services: Software (Patient Information Systems, Treatment Planning Systems), Professional Services; Application: Medical Oncology, Surgical Oncology, Radiation Oncology) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026”, offers a detailed insights on the global oncology information systems market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. Information about porter's five forces analysis is also covered under the report scope. The report provides insights on global oncology information systems market, its medical treatment, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global oncology information systems market size and volume, and segment markets by products & services, application, and geography along with the information on companies operating in the market. The oncology information systems market analysis is provided for major regional markets including North America, Europe, China, Southeast Asia, Japan and India followed by major countries. For each region, the market size and volume for different segments has been covered under the scope of report. North America region is accounted for the largest share of the oncology information systems market, followed by Europe in present years. Furthermore, the Asia-Pacific market is likely to grow at the highest CAGR during the upcoming period due to high growth can be attributed to the increasing focus of the market players on developing nations. The players profiled in the report include Elekta AB, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron and among others.
Market By Products & Services
Market By Application
Market By Geography
Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco
Introduction According to Acumen Research and Consulting, the global Sports Medicine market is expected to grow at noteworthy CAGR around 7% throughout the forecast period and reach around US$ 13 billion by 2026. Sports Medicine is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopathie
Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence
Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza
Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to
Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa